IRIS
CAPODANNO, DAVIDE FRANCESCO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.196
EU - Europa 6.433
AS - Asia 5.622
SA - Sud America 993
AF - Africa 582
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 3
Totale 27.845
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.493
SG - Singapore 2.969
CN - Cina 2.071
IE - Irlanda 1.914
UA - Ucraina 1.775
IT - Italia 1.091
BR - Brasile 929
CA - Canada 659
RU - Federazione Russa 535
CI - Costa d'Avorio 459
SE - Svezia 281
GR - Grecia 193
VN - Vietnam 186
DE - Germania 130
GB - Regno Unito 120
IN - India 79
FI - Finlandia 62
FR - Francia 60
CH - Svizzera 59
SN - Senegal 59
KR - Corea 57
UZ - Uzbekistan 48
AT - Austria 47
NL - Olanda 42
TR - Turchia 34
BD - Bangladesh 33
IQ - Iraq 33
PL - Polonia 32
BE - Belgio 26
MX - Messico 22
AR - Argentina 21
HK - Hong Kong 21
JP - Giappone 19
ZA - Sudafrica 19
NG - Nigeria 16
EU - Europa 15
VE - Venezuela 15
ES - Italia 14
MA - Marocco 13
CZ - Repubblica Ceca 12
EC - Ecuador 11
PK - Pakistan 11
BG - Bulgaria 9
LB - Libano 9
KE - Kenya 8
CO - Colombia 7
JM - Giamaica 6
JO - Giordania 6
NP - Nepal 6
PH - Filippine 6
AZ - Azerbaigian 5
AL - Albania 4
BY - Bielorussia 4
CR - Costa Rica 4
EG - Egitto 4
PE - Perù 4
RS - Serbia 4
SA - Arabia Saudita 4
BH - Bahrain 3
BO - Bolivia 3
GE - Georgia 3
HN - Honduras 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
IL - Israele 2
IR - Iran 2
MK - Macedonia 2
MY - Malesia 2
RO - Romania 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
HU - Ungheria 1
ID - Indonesia 1
IS - Islanda 1
LU - Lussemburgo 1
MD - Moldavia 1
NO - Norvegia 1
PY - Paraguay 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 27.845
Salva come PNG Salva come JPEG
Città #
Jacksonville 2.344
Santa Clara 2.007
Dublin 1.911
Singapore 1.779
Chandler 1.363
Boardman 921
Nanjing 637
Houston 621
Lawrence 535
Andover 530
Cambridge 529
Toronto 498
Abidjan 459
Chicago 418
Catania 395
Ashburn 389
Des Moines 372
Nanchang 227
San Mateo 227
Civitanova Marche 201
Wilmington 186
Hebei 173
Shenyang 151
Dong Ket 141
Athens 136
Ottawa 134
Hefei 128
Jiaxing 115
Tianjin 113
Saint Petersburg 112
Changsha 88
Beijing 73
São Paulo 70
Milan 67
Los Angeles 66
Dakar 59
Seoul 57
Washington 56
Moscow 52
Seattle 44
Bremen 41
Lappeenranta 41
Rome 41
Norwalk 40
Hangzhou 38
Kunming 33
Jinan 32
Hanoi 30
Ningbo 29
Pune 29
Rio de Janeiro 29
Belo Horizonte 26
Brussels 26
Brooklyn 25
Columbus 24
Den Haag 24
Liberty Lake 23
The Dalles 23
Zhengzhou 23
Palermo 22
Council Bluffs 20
Helsinki 19
Hong Kong 19
Gravina di Catania 18
Phoenix 17
Abuja 16
Edinburgh 16
Munich 16
Taizhou 16
Ann Arbor 15
Curitiba 15
New York 15
Tashkent 15
Brasília 14
Guangzhou 14
Porto Alegre 14
San Francisco 14
Frankfurt Am Main 13
Padova 13
Pozzo Di Gotto 13
Warsaw 13
Falls Church 12
Guarulhos 12
Manduria 12
Campinas 11
Shanghai 11
Stockholm 11
Tokyo 11
Aigaleo 10
Changchun 10
Montreal 10
Nuremberg 10
Redwood City 10
Salvador 10
Secaucus 10
Atlanta 9
Baghdad 9
Dallas 9
Dhaka 9
Fortaleza 9
Totale 19.503
Salva come PNG Salva come JPEG
Nome #
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients 516
Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold 227
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the GHOST-EU and XIENCE V USA Registries 140
Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the Age, Creatinine, Ejection Fraction [ACEF] score in patients undergoing percutaneous coronary intervention 128
A Risk Model for Prediction of One-Year Mortality in Patients Undergoing MitraClip Implantation 125
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity. 98
SYNTAX Score II predicts carotid disease in a multivessel coronary disease population 92
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry. 89
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 89
Miocardio non compattato del ventricolo sinistro e aneurisma del setto interatriale con difetto. Associazione casuale? 88
Prevalence of renal artery stenosis in patients undergoing cardiac catheterization 87
[Management of severe stenosis controversies and promises] 87
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score 87
A focused update on emerging prognostic determinants in distal left main percutaneous coronary intervention 85
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 85
A comparison between Endeavor and Endeavor Resolute drug-eluting stents: outcome at six months follow up 83
Recent acquisitions and advances in the knowledge of coronary flow disturbances after percutaneous coronary intervention 82
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 82
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients 81
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 80
The treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds 79
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study 78
Temporal patterns of early neointimal strut coverage of the CATANIA stent compared with drug eluting stents and bare metal stent: the Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 77
Intraoperative defibrillation threshold testing durino implantable cardioverter-defibrillator insertion: Do we really need it? 77
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 77
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement 77
Predictive Accuracy of CHA2DS2-VASc and HAS-BLED Scores In Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention And Discharged On Dual Antiplatelet Therapy 77
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement 77
Clinical implication of different plaque distribution patterns in distal left main coronary artery 76
Acute Left Atrial Spontaneous Echo Contrast and Suspicious Thrombus Formation Following Mitral Regurgitation Reduction With The MitraClip System 76
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 76
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair 75
Antithrombotic Therapy for Secondary Prevention in Patients with Cerebrovascular Disease 75
Association of Tricuspid Regurgitation With Clinical and Echocardiographic Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Thirty-Day and Twelve-Month Follow-up From the GRASP Registry 75
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. 75
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry 75
Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. 74
Three-Dimensional Angle Assessment and Plaque Distribution Classification in Left Main Disease: Impact of Geometry on Outcome 74
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in Left Main Patients with Intermediate Global Risk 74
A novel 3-d reconstruction system for the assessment of bifurcation lesions treated by the mini-crush technique 74
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial 74
Diabetes mellitus: the scary killer haunting silently 73
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery 73
Very Late Outcomes of Drug-Eluting Stents: The "Catch-Down" Phenomenon 73
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair 73
Standardised Definitions of Structural Deterioration and Valve Failure in Assessing Long-Term Durability of Transcatheter and Surgical Aortic Bioprosthetic Valves: A Consensus Statement from The European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 73
Transcatheter aortic valve implantation in 2017: state of the art 73
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 73
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. 73
Antithrombotic Therapy in Patients with Chronic Kidney Disease 72
Reply: Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome 72
Quality of life assessment after percutaneous aortic valve implantation 72
Is the metallic stent a safe treatment for bioresorbable scaffold failure? Insights from optical coherence tomography 72
Bioresorbable vascular scaffold in patients with complex coronary artery disease. 72
A Multidisciplinary Consensus Document on Follow-up Strategies for Patients Treated with Percutaneous Coronary Intervention 72
Long-term clinical and echocardiographic outcomes of Mitraclip therapy in patients nonresponders to cardiac resynchronization 72
Tailoring duration of DAPT with risk scores 71
CORONARY REMODELLING AFTER RECANALIZATION OF CHRONIC TOTAL OCCLUSION 71
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. 71
Long-term bleeding events in patients with prolonged dual antiplatelet therapy after DES implantation 71
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture 70
Upcoming TAVI trials: rationale, design and likely impact on clinical practice 70
Haemostatic Profiles Assessed by Thromboelastography in Patients with End-Stage Renal Disease 70
Local delivery versus intracoronary infusion of abciximab in patients with acute coronary syndromes 70
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs? 70
Effects of Cangrelor in Coronary Artery Disease Patients With and Without Diabetes Mellitus: An In Vitro Pharmacodynamic Investigation 70
Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. 70
A comparison between Endeavor and Endeavor Resolute drug-eluting coronary stents: outcomes at six month follow up 70
EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention 69
Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies 69
Emerging strategies for rapid reversal of anticoagulation in patients undergoing catheter-based interventions: aptamers enter the RADAR 69
The inflammatory abdominal aortic aneurysm and coronary artery disease. Case report and review 69
Coronary revascularization strategies in patients with multivessel disease: is it all about diabetes? 69
Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts 69
Early discharge in acute myocardial infarction after clinical and angiographic risk assessment 68
Long-Term Follow-Up after Drug Eluting Stent Implantation in Left Main Trifurcations 68
Mechanisms, Pathophysiology, and Clinical Aspects of Incomplete Stent Apposition 68
Spontaneous coronary artery dissection 68
Reply: plaque rupture in stable coronary artery disease 68
New-onset coronary aneurism and late-acquired incomplete scaffold apposition after full polymer jacket of a chronic total occlusion with bioresorbable scaffolds 68
Functional profile of the platelet P2Y12 receptor signaling pathway in patients with diabetes mellitus and coronary artery disease 68
Update on clinical evidence (Part II): a summary of the main post market studies 68
Fate of Non-Culprit Plaques in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Followed by Statin Therapy: A Serial Optical Coherence Tomography Analysis From the OCTAVIA Study 68
Management issues of chronic therapy with non-vitamin K oral anticolagulants or antiplatelet agents: different or alike? 67
Impact of race and gender on antithrombotic therapy 67
Bivalirudin For Acute Coronary Syndromes: Premises, Promises and Doubts 67
Risk stratification after ST-elevation myocardial infarction 67
Optimal P2Y12 inhibitor for primary PCI in STEMI: Network meta-analysis in the data-fre zone. Do you believe in magic? 67
Volumetric Assessment of Lesion Severity with Optical Coherence Tomography: Relationship with Fractional Flow Reserve 67
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice 67
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 66
Progresses in interventional cardiology: focus on patent foramen ovale, coronary intervention, antithrombotic pharmacology, and more 66
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations 66
Mini-crush versus T-provisional techniques in bifurcation lesions: clinical and angiographic long term outcome after implantation of drug–eluting stents 65
Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery in Left Main Coronary Artery Disease: a Meta-Analysis of Randomized Clinical Data 65
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST- EU Registry - Reply 65
Contrast Transesophageal Echocardiography Using the AcuNav Ultrasound Catheter Through Mouth Way as a Guide to Percutaneous Closure of Patent Foramen Ovale 65
Radial access reduces mortality in patients with acute coronary syndromes. Results from an updated trial sequential analysis of randomized trials 64
The optimal pharmacological formula for percutaneous coronary intervention 64
Percutaneous Coronary Intervention With Everolimus-Eluting Bioresorbable Vascular Scaffolds In Routine Clinical Practice: Early and Mid-Term Outcomes From The European Multicenter GHOST-EU Registry 64
Totale 8.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.025
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.205 12 228 492 7 821 112 495 6 264 24 518 226
2021/20223.761 494 579 11 50 618 12 558 99 331 5 83 921
2022/20235.180 545 67 40 349 671 985 9 814 1.432 34 172 62
2023/20242.393 125 494 111 192 100 372 50 104 17 79 472 277
2024/20258.376 96 1.246 605 325 1.999 674 153 360 706 968 450 794
2025/2026541 541 0 0 0 0 0 0 0 0 0 0 0
Totale 28.613